Chardan Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

Brokerage Ranking

Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Total Ratings

289 Last 12 Months

Buy Ratings

272 Last 12 Months

Sell Ratings

0 Last 12 Months

Companies Covered

66 Last 12 Months

Country USA (NYSE & NASDAQ)

• USA (NYSE & NASDAQ)
• USA (All Exchanges)
• Canada
• United Kingdom

Sector All Sectors

• Aerospace
• Auto/Tires/Trucks
• Basic Materials
• Business Services
• Communication Services
• Computer and Technology
• Construction
• Consumer Cyclical
• Consumer Defensive
• Consumer Discretionary
• Consumer Goods
• Consumer Staples
• Energy
• Finance
• Financial Services
• Industrials
• Manufacturing
• Medical
• Miscellaneous
• Multi-Sector Conglomerates
• Real Estate
• Retail/Wholesale
• Services
• Transportation
• Utilities

Market Cap All MarketCaps

• Mega Cap (More Than $200B)
• Large Cap ($10B-$200B)
• Mid Cap ($2B-$10B)
• Small Cap ($300M-$2B)
• Micro Cap ($50M-$300M)
• Nano Cap (Under $50M)

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription

MarketRank™Upgrade to All Access to use the All Ranks Filter

Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription

Media SentimentUpgrade to All Access to use the All Sentiments Filter

Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription

Analyst ConsensusUpgrade to All Access to use the All Ratings Filter

Reporting Date

Export to Excel

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	12-Month Recommendation ROI	Details
COYA Coya Therapeutics	$5.74 +6.1%	9/17/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 9/17/2025
MNPR Monopar Therapeutics	$66.25 -0.6%	9/16/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy	00.00%	View details for Chardan Capital rating of Monopar Therapeutics (NASDAQ:MNPR) on 9/16/2025
OCUL Ocular Therapeutix	$12.71 +4.5%	9/15/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$21.00	Buy	00.00%	View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 9/15/2025
RNA Avidity Biosciences	$41.81 +4.4%	9/10/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$75.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 9/10/2025
TRML Tourmaline Bio	$47.69 0.0%	9/10/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$70.00 ➝ $48.00	Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 9/10/2025
RGNX REGENXBIO	$9.36 +3.7%	9/8/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$52.00	Buy	00.00%	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 9/8/2025
QURE uniQure	$14.76 +4.2%	9/8/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 9/8/2025
CLSK Cleanspark	$13.46 +17.7%	9/8/2025	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 9/8/2025
VFS VinFast Auto	$3.28 +1.2%	9/5/2025	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.50	Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 9/5/2025
QURE uniQure	$14.76 +4.2%	8/29/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/29/2025
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
OTLK Oncobiologics	$0.99 -2.9%	8/28/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$3.00	Neutral	00.00%	View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 8/28/2025
PRTA Prothena	$8.18 +1.5%	8/28/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Buy	00.00%	View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 8/28/2025
KRYS Krystal Biotech	$160.61 +4.3%	8/22/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$219.00 ➝ $216.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/22/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	8/20/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/20/2025
LXEO Lexeo Therapeutics	$5.46 +1.9%	8/15/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$20.00 ➝ $15.00	Buy	00.00%	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 8/15/2025
MGX Metagenomi	$2.14 +13.8%	8/15/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$12.00 ➝ $11.00	Buy	00.00%	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 8/15/2025
PVLA Palvella Therapeutics	$59.04 +4.4%	8/15/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$50.00 ➝ $60.00	Buy	00.00%	View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 8/15/2025
MGTX MeiraGTx	$7.99 +9.0%	8/15/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Buy	00.00%	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/15/2025
OTLK Oncobiologics	$0.99 -2.9%	8/15/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$3.00	Neutral	00.00%	View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 8/15/2025
ZURA Zura Bio	$2.05 +7.9%	8/15/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	00.00%	View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/15/2025
FBRX Forte Biosciences	$13.21 +10.5%	8/15/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$61.00	Buy	00.00%	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 8/15/2025
IMRX Immuneering	$9.01 +11.6%	8/14/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00	Buy	00.00%	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/14/2025
TRML Tourmaline Bio	$47.69 0.0%	8/14/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$70.00	Buy	00.00%	View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 8/14/2025
SLDB Solid Biosciences	$5.44 -0.5%	8/14/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Buy	00.00%	View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 8/14/2025
VFS VinFast Auto	$3.28 +1.2%	8/14/2025	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.50	Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 8/14/2025
OBIO Orchestra BioMed	$2.51 +2.0%	8/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/13/2025
MNPR Monopar Therapeutics	$66.25 -0.6%	8/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy	00.00%	View details for Chardan Capital rating of Monopar Therapeutics (NASDAQ:MNPR) on 8/13/2025
KRRO Korro Bio	$33.22 +9.3%	8/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	00.00%	View details for Chardan Capital rating of Korro Bio (NASDAQ:KRRO) on 8/13/2025
STOK Stoke Therapeutics	$23.50 +3.3%	8/13/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$24.00	Buy	00.00%	View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 8/13/2025
ADVM Adverum Biotechnologies	$2.95 +2.4%	8/13/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.00	Buy	00.00%	View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/13/2025
COYA Coya Therapeutics	$5.74 +6.1%	8/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/13/2025
TSHA Taysha Gene Therapies	$2.99 +3.1%	8/12/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$9.00 ➝ $10.00	Buy	00.00%	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/12/2025
CNTA Centessa Pharmaceuticals	$22.97 +5.1%	8/12/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00	Buy	00.00%	View details for Chardan Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 8/12/2025
XENE Xenon Pharmaceuticals	$37.76 +2.9%	8/12/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$55.00	Buy	00.00%	View details for Chardan Capital rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/12/2025
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	8/12/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/12/2025
DIS Walt Disney	$114.90 -1.0%	8/11/2025		Reiterated Rating		Buy	00.00%	View details for Chardan Capital rating of Walt Disney (NYSE:DIS) on 8/11/2025
ABUS Arbutus Biopharma	$4.42 -0.2%	8/11/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.00	Buy	00.00%	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/11/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	8/11/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$12.00 ➝ $11.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2025
NTLA Intellia Therapeutics	$16.11 +29.8%	8/11/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$68.00 ➝ $60.00	Buy	00.00%	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/11/2025
ARWR Arrowhead Pharmaceuticals	$31.51 +8.2%	8/11/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy	00.00%	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/11/2025
CRVO CervoMed	$8.10 +4.0%	8/11/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Buy	00.00%	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 8/11/2025
SNTI Senti Biosciences	$1.39 +1.5%	8/8/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00	Buy	00.00%	View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 8/8/2025
PRME Prime Medicine	$5.12 +10.1%	8/8/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$12.00 ➝ $10.00	Buy	00.00%	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 8/8/2025
RNA Avidity Biosciences	$41.81 +4.4%	8/8/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$75.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/8/2025
IOVA Iovance Biotherapeutics	$2.20 -0.9%	8/8/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$25.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/8/2025
PRQR ProQR Therapeutics	$2.19 +6.3%	8/8/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.00	Buy	00.00%	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/8/2025
CLSK Cleanspark	$13.46 +17.7%	8/8/2025	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 8/8/2025
SABS SAB Biotherapeutics	$2.79 +8.1%	8/8/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$20.00 ➝ $12.00	Buy	00.00%	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 8/8/2025
CGTX Cognition Therapeutics	$1.47	8/8/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.00	Buy	00.00%	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 8/8/2025
RGNX REGENXBIO	$9.36 +3.7%	8/8/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$52.00	Buy	00.00%	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/8/2025
TNYA Tenaya Therapeutics	$1.32 +8.2%	8/7/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00	Buy	00.00%	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/7/2025
EYPT Eyepoint Pharmaceuticals	$13.76 +0.9%	8/7/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$27.00	Buy	00.00%	View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/7/2025
OBIO Orchestra BioMed	$2.51 +2.0%	8/7/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/7/2025
CRSP CRISPR Therapeutics	$62.94 +6.6%	8/5/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$82.00	Buy	00.00%	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/5/2025
KRYS Krystal Biotech	$160.61 +4.3%	8/5/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$219.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/5/2025
PRTA Prothena	$8.18 +1.5%	8/5/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Buy	00.00%	View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 8/5/2025
OCGN Ocugen	$1.40 +6.1%	8/4/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 8/4/2025
ALNY Alnylam Pharmaceuticals	$452.17 +0.1%	8/1/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$325.00 ➝ $400.00	Buy	00.00%	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/1/2025
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	8/1/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/1/2025
MNMD Mind Medicine (MindMed)	$9.48 -0.9%	8/1/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 8/1/2025
CNTA Centessa Pharmaceuticals	$22.97 +5.1%	7/30/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00	Buy	00.00%	View details for Chardan Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 7/30/2025
QURE uniQure	$14.76 +4.2%	7/29/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$38.00 ➝ $35.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/29/2025
DYN Dyne Therapeutics	$13.92 +5.9%	7/29/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$50.00 ➝ $38.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 7/29/2025
PRAX Praxis Precision Medicines	$45.23 +2.7%	7/29/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$80.00	Buy	00.00%	View details for Chardan Capital rating of Praxis Precision Medicines (NASDAQ:PRAX) on 7/29/2025
KRYS Krystal Biotech	$160.61 +4.3%	7/25/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$219.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 7/25/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	7/24/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$17.00 ➝ $12.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 7/24/2025
IOVA Iovance Biotherapeutics	$2.20 -0.9%	7/23/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	00.00%	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 7/23/2025
CLSD Clearside Biomedical	$3.89 +7.8%	7/18/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 7/18/2025
CLSK Cleanspark	$13.46 +17.7%	7/8/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/8/2025
VFS VinFast Auto	$3.28 +1.2%	7/7/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.50	Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 7/7/2025
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	7/3/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/3/2025
COYA Coya Therapeutics	$5.74 +6.1%	7/1/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 7/1/2025
CRSP CRISPR Therapeutics	$62.94 +6.6%	6/26/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$82.00	Buy	00.00%	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 6/26/2025
IBIO iBio	$0.87 +3.2%	6/25/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.00	Buy	00.00%	View details for Chardan Capital rating of iBio (NYSE:IBIO) on 6/25/2025
CLSK Cleanspark	$13.46 +17.7%	6/25/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 6/25/2025
PASG Passage Bio	$7.50 +6.7%	6/24/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	00.00%	View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 6/24/2025
FBRX Forte Biosciences	$13.21 +10.5%	6/24/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$61.00	Buy	00.00%	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 6/24/2025
OCGN Ocugen	$1.40 +6.1%	6/24/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 6/24/2025
VFS VinFast Auto	$3.28 +1.2%	6/23/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.50	Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 6/23/2025
MNPR Monopar Therapeutics	$66.25 -0.6%	6/23/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$60.00	Buy	00.00%	View details for Chardan Capital rating of Monopar Therapeutics (NASDAQ:MNPR) on 6/23/2025
IMRX Immuneering	$9.01 +11.6%	6/18/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00	Buy	00.00%	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 6/18/2025
DYN Dyne Therapeutics	$13.92 +5.9%	6/17/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 6/17/2025
SNTI Senti Biosciences	$1.39 +1.5%	6/12/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00	Buy	00.00%	View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 6/12/2025
VFS VinFast Auto	$3.28 +1.2%	6/10/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.50	Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 6/10/2025
RNA Avidity Biosciences	$41.81 +4.4%	6/9/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$65.00 ➝ $75.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 6/9/2025
RGNX REGENXBIO	$9.36 +3.7%	6/9/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$52.00	Buy	00.00%	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 6/9/2025
QURE uniQure	$14.76 +4.2%	5/30/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/30/2025
WBX Wallbox	$4.11 -0.1%	5/28/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold	00.00%	View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 5/28/2025
TSHA Taysha Gene Therapies	$2.99 +3.1%	5/29/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$7.00 ➝ $9.00	Buy	00.00%	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/29/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	5/28/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$46.00 ➝ $17.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/28/2025
PRTA Prothena	$8.18 +1.5%	5/27/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$40.00 ➝ $18.00	Buy	00.00%	View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 5/27/2025
DRUG Bright Minds Biosciences	$50.15 +12.2%	5/21/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$80.00 ➝ $80.00	Buy	00.00%	View details for Chardan Capital rating of Bright Minds Biosciences (NASDAQ:DRUG) on 5/21/2025
CLSK Cleanspark	$13.46 +17.7%	5/21/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$26.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 5/21/2025
PRME Prime Medicine	$5.12 +10.1%	5/19/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$16.00 ➝ $12.00	Buy	00.00%	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 5/19/2025
SLDB Solid Biosciences	$5.44 -0.5%	5/19/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$16.00 ➝ $15.00	Buy	00.00%	View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 5/19/2025
IPSC Century Therapeutics	$0.51 +3.1%	5/16/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.00 ➝ $6.00	Buy	00.00%	View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 5/16/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	5/16/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$45.00 ➝ $46.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/16/2025
SABS SAB Biotherapeutics	$2.79 +8.1%	5/15/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/15/2025
ADVM Adverum Biotechnologies	$2.95 +2.4%	5/15/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.00 ➝ $33.00	Buy	00.00%	View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 5/15/2025
MGX Metagenomi	$2.14 +13.8%	5/15/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$13.00 ➝ $12.00	Buy	00.00%	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 5/15/2025
MGTX MeiraGTx	$7.99 +9.0%	5/14/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$38.00 ➝ $35.00	Buy	00.00%	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 5/14/2025
COYA Coya Therapeutics	$5.74 +6.1%	5/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00 ➝ $14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/13/2025
KRRO Korro Bio	$33.22 +9.3%	5/13/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of Korro Bio (NASDAQ:KRRO) on 5/13/2025
OBIO Orchestra BioMed	$2.51 +2.0%	5/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 5/13/2025
LXEO Lexeo Therapeutics	$5.46 +1.9%	5/13/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$22.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 5/13/2025
ARWR Arrowhead Pharmaceuticals	$31.51 +8.2%	5/13/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00 ➝ $60.00	Buy	00.00%	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/13/2025
XENE Xenon Pharmaceuticals	$37.76 +2.9%	5/13/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$55.00 ➝ $55.00	Buy	00.00%	View details for Chardan Capital rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 5/13/2025
CRVO CervoMed	$8.10 +4.0%	5/12/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$14.00 ➝ $15.00	Buy	00.00%	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 5/12/2025
QURE uniQure	$14.76 +4.2%	5/12/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00 ➝ $38.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/12/2025
OCGN Ocugen	$1.40 +6.1%	5/12/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00 ➝ $7.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/12/2025
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	5/9/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$28.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 5/9/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	5/9/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$54.00 ➝ $45.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/9/2025
IOVA Iovance Biotherapeutics	$2.20 -0.9%	5/9/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$30.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/9/2025
OCS Oculis	$17.35 -0.3%	5/9/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$28.00 ➝ $33.00	Buy	00.00%	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 5/9/2025
DYN Dyne Therapeutics	$13.92 +5.9%	5/9/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00 ➝ $50.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/9/2025
PRTA Prothena	$8.18 +1.5%	5/9/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00 ➝ $40.00	Buy	00.00%	View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 5/9/2025
TNYA Tenaya Therapeutics	$1.32 +8.2%	5/9/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00 ➝ $9.00	Buy	00.00%	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 5/9/2025
NTLA Intellia Therapeutics	$16.11 +29.8%	5/9/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$68.00 ➝ $68.00	Buy	00.00%	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/9/2025
MNMD Mind Medicine (MindMed)	$9.48 -0.9%	5/9/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/9/2025
EYPT Eyepoint Pharmaceuticals	$13.76 +0.9%	5/8/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$33.00 ➝ $27.00	Buy	00.00%	View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 5/8/2025
CGTX Cognition Therapeutics	$1.47	5/8/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$8.00 ➝ $4.00	Buy	00.00%	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 5/8/2025
MCRB Seres Therapeutics	$18.03 +2.4%	5/8/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$1.25 ➝ $6.00	Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2025
CNTA Centessa Pharmaceuticals	$22.97 +5.1%	5/8/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$30.00	Buy	00.00%	View details for Chardan Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 5/8/2025
DRUG Bright Minds Biosciences	$50.15 +12.2%	5/7/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$80.00	Buy	00.00%	View details for Chardan Capital rating of Bright Minds Biosciences (NASDAQ:DRUG) on 5/7/2025
PRAX Praxis Precision Medicines	$45.23 +2.7%	5/7/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$80.00	Buy	00.00%	View details for Chardan Capital rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/7/2025
CRSP CRISPR Therapeutics	$62.94 +6.6%	5/7/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$84.00 ➝ $82.00	Buy	00.00%	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/7/2025
XENE Xenon Pharmaceuticals	$37.76 +2.9%	5/7/2025	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$55.00	Buy	00.00%	View details for Chardan Capital rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 5/7/2025
RNA Avidity Biosciences	$41.81 +4.4%	5/7/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00 ➝ $65.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/7/2025
KRYS Krystal Biotech	$160.61 +4.3%	5/7/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$219.00 ➝ $219.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 5/7/2025
IMRX Immuneering	$9.01 +11.6%	5/6/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00 ➝ $13.00	Buy	00.00%	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 5/6/2025
QURE uniQure	$14.76 +4.2%	5/6/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00 ➝ $38.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/6/2025
IBIO iBio	$0.87 +3.2%	5/5/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.00 ➝ $5.00	Buy	00.00%	View details for Chardan Capital rating of iBio (NYSE:IBIO) on 5/5/2025
TRML Tourmaline Bio	$47.69 0.0%	5/5/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$70.00 ➝ $70.00	Buy	00.00%	View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 5/5/2025
SNTI Senti Biosciences	$1.39 +1.5%	5/2/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00 ➝ $12.00	Buy	00.00%	View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 5/2/2025
ALNY Alnylam Pharmaceuticals	$452.17 +0.1%	5/2/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$300.00 ➝ $325.00	Buy	00.00%	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/2/2025
WBX Wallbox	$4.11 -0.1%	4/29/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold	00.00%	View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 4/29/2025
VFS VinFast Auto	$3.28 +1.2%	4/29/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/29/2025
CLSK Cleanspark	$13.46 +17.7%	4/29/2025	J. Mcilree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 4/29/2025
COYA Coya Therapeutics	$5.74 +6.1%	4/28/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00 ➝ $14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/28/2025
VFS VinFast Auto	$3.28 +1.2%	4/28/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00 ➝ $5.50	Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/28/2025
TRML Tourmaline Bio	$47.69 0.0%	4/23/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$70.00	Buy	00.00%	View details for Chardan Capital rating of Tourmaline Bio (NASDAQ:TRML) on 4/23/2025
OBIO Orchestra BioMed	$2.51 +2.0%	4/22/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 4/22/2025
OCS Oculis	$17.35 -0.3%	4/17/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$28.00 ➝ $28.00	Buy	00.00%	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 4/17/2025
ADVM Adverum Biotechnologies	$2.95 +2.4%	4/17/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$40.00 ➝ $33.00	Buy	00.00%	View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/17/2025
KRRO Korro Bio	$33.22 +9.3%	4/16/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$25.00	Buy	00.00%	View details for Chardan Capital rating of Korro Bio (NASDAQ:KRRO) on 4/16/2025
PVLA Palvella Therapeutics	$59.04 +4.4%	4/9/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$50.00	Buy	00.00%	View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 4/9/2025
LXEO Lexeo Therapeutics	$5.46 +1.9%	4/8/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$25.00 ➝ $22.00	Buy	00.00%	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 4/8/2025
SONN Sonnet BioTherapeutics	$7.58 +7.4%	4/7/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Sonnet BioTherapeutics (NASDAQ:SONN) on 4/7/2025
OBIO Orchestra BioMed	$2.51 +2.0%	4/1/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 4/1/2025
FBRX Forte Biosciences	$13.21 +10.5%	4/1/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$64.00 ➝ $61.00	Buy	00.00%	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 4/1/2025
SABS SAB Biotherapeutics	$2.79 +8.1%	4/1/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$25.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/1/2025
QURE uniQure	$14.76 +4.2%	4/1/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$27.00 ➝ $38.00	Buy	00.00%	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 4/1/2025
CLSD Clearside Biomedical	$3.89 +7.8%	3/28/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$90.00 ➝ $90.00	Buy	00.00%	View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 3/28/2025
SONN Sonnet BioTherapeutics	$7.58 +7.4%	3/28/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Sonnet BioTherapeutics (NASDAQ:SONN) on 3/28/2025
ABUS Arbutus Biopharma	$4.42 -0.2%	3/28/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.00 ➝ $5.00	Buy	00.00%	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/28/2025
GANX Gain Therapeutics	$1.70 +7.6%	3/28/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00 ➝ $6.00	Buy	00.00%	View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/28/2025
ALUR Allurion Technologies	$2.07 -2.4%	3/27/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.50 ➝ $2.50	Neutral	00.00%	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 3/27/2025
ZURA Zura Bio	$2.05 +7.9%	3/26/2025	Matthew Barcus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$12.00 ➝ $10.00	Buy	00.00%	View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025
WBX Wallbox	$4.11 -0.1%	3/24/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold	00.00%	View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 3/24/2025
VFS VinFast Auto	$3.28 +1.2%	3/24/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	00.00%	View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 3/24/2025
CLSK Cleanspark	$13.46 +17.7%	3/24/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	00.00%	View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 3/24/2025
LXEO Lexeo Therapeutics	$5.46 +1.9%	3/25/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 3/25/2025
IMRX Immuneering	$9.01 +11.6%	3/24/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$13.00 ➝ $13.00	Buy	00.00%	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/24/2025
IPSC Century Therapeutics	$0.51 +3.1%	3/24/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$11.00 ➝ $7.00	Buy	00.00%	View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 3/24/2025
ALNY Alnylam Pharmaceuticals	$452.17 +0.1%	3/21/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$300.00 ➝ $300.00	Buy	00.00%	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/21/2025
ALUR Allurion Technologies	$2.07 -2.4%	3/21/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.50	Neutral	00.00%	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 3/21/2025
CGTX Cognition Therapeutics	$1.47	3/21/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$11.00 ➝ $8.00	Buy	00.00%	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/21/2025
MCRB Seres Therapeutics	$18.03 +2.4%	3/20/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/20/2025
RGNX REGENXBIO	$9.36 +3.7%	3/20/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$52.00 ➝ $52.00	Buy	00.00%	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/20/2025
PRME Prime Medicine	$5.12 +10.1%	3/20/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$15.00 ➝ $16.00	Buy	00.00%	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 3/20/2025
COYA Coya Therapeutics	$5.74 +6.1%	3/20/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00 ➝ $14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2025
STOK Stoke Therapeutics	$23.50 +3.3%	3/19/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$24.00 ➝ $24.00	Buy	00.00%	View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 3/19/2025
RNA Avidity Biosciences	$41.81 +4.4%	3/17/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00 ➝ $65.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/17/2025
DYN Dyne Therapeutics	$13.92 +5.9%	3/17/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00 ➝ $50.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/17/2025
PRQR ProQR Therapeutics	$2.19 +6.3%	3/14/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.00 ➝ $4.00	Buy	00.00%	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2025
RGNX REGENXBIO	$9.36 +3.7%	3/14/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$52.00 ➝ $52.00	Buy	00.00%	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/14/2025
OCS Oculis	$17.35 -0.3%	3/13/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$28.00 ➝ $28.00	Buy	00.00%	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/13/2025
CRVO CervoMed	$8.10 +4.0%	3/13/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$14.00 ➝ $14.00	Neutral ➝ Buy	00.00%	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 3/13/2025
TNYA Tenaya Therapeutics	$1.32 +8.2%	3/12/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$18.00 ➝ $9.00	Buy	00.00%	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/12/2025
SLDB Solid Biosciences	$5.44 -0.5%	3/7/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00 ➝ $16.00	Buy	00.00%	View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 3/7/2025
EYPT Eyepoint Pharmaceuticals	$13.76 +0.9%	3/6/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.00 ➝ $33.00	Buy	00.00%	View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 3/6/2025
OCGN Ocugen	$1.40 +6.1%	3/6/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$6.00 ➝ $7.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/6/2025
PASG Passage Bio	$7.50 +6.7%	3/4/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$140.00 ➝ $120.00	Buy	00.00%	View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 3/4/2025
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	3/4/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$30.00 ➝ $28.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 3/4/2025
PRME Prime Medicine	$5.12 +10.1%	3/3/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00 ➝ $15.00	Buy	00.00%	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 3/3/2025
IOVA Iovance Biotherapeutics	$2.20 -0.9%	3/3/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$34.00 ➝ $30.00	Buy	00.00%	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 3/3/2025
NTLA Intellia Therapeutics	$16.11 +29.8%	2/28/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$91.00 ➝ $68.00	Buy	00.00%	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/28/2025
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	2/28/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$62.00 ➝ $54.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/28/2025
DYN Dyne Therapeutics	$13.92 +5.9%	2/28/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00 ➝ $50.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 2/28/2025
RNA Avidity Biosciences	$41.81 +4.4%	2/28/2025	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00 ➝ $65.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/28/2025
CGTX Cognition Therapeutics	$1.47	2/26/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00 ➝ $11.00	Buy	00.00%	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 2/26/2025
TSHA Taysha Gene Therapies	$2.99 +3.1%	2/26/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00 ➝ $7.00	Buy	00.00%	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 2/26/2025
ALNY Alnylam Pharmaceuticals	$452.17 +0.1%	2/26/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$300.00 ➝ $300.00	Buy	00.00%	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/26/2025
MGTX MeiraGTx	$7.99 +9.0%	2/24/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$36.00 ➝ $36.00	Buy	00.00%	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 2/24/2025
PRTA Prothena	$8.18 +1.5%	2/21/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00 ➝ $40.00	Buy	00.00%	View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 2/21/2025
KRYS Krystal Biotech	$160.61 +4.3%	2/20/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$212.00 ➝ $218.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 2/20/2025
SLDB Solid Biosciences	$5.44 -0.5%	2/19/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$15.00 ➝ $16.00	Buy	00.00%	View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 2/19/2025
STOK Stoke Therapeutics	$23.50 +3.3%	2/19/2025	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$24.00 ➝ $24.00	Buy	00.00%	View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 2/19/2025
OTLK Oncobiologics	$0.99 -2.9%	2/18/2025	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$3.00 ➝ $3.00	Neutral	00.00%	View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 2/18/2025
OCGN Ocugen	$1.40 +6.1%	2/13/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00 ➝ $6.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 2/13/2025
CRSP CRISPR Therapeutics	$62.94 +6.6%	2/13/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$94.00 ➝ $84.00	Buy	00.00%	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/13/2025
ARWR Arrowhead Pharmaceuticals	$31.51 +8.2%	2/11/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00 ➝ $60.00	Buy	00.00%	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/11/2025
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	2/11/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$39.00 ➝ $30.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 2/11/2025
COYA Coya Therapeutics	$5.74 +6.1%	2/6/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00 ➝ $14.00	Buy	00.00%	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025
EYPT Eyepoint Pharmaceuticals	$13.76 +0.9%	2/6/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.00 ➝ $33.00	Buy	00.00%	View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 2/6/2025
CRGX CARGO Therapeutics	$4.47	1/30/2025	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 1/30/2025
SABS SAB Biotherapeutics	$2.79 +8.1%	1/29/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 1/29/2025
OCGN Ocugen	$1.40 +6.1%	1/23/2025	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00 ➝ $6.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 1/23/2025
DYN Dyne Therapeutics	$13.92 +5.9%	1/10/2025	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00 ➝ $50.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 1/10/2025
IMRX Immuneering	$9.01 +11.6%	1/8/2025		Reiterated Rating	$13.00 ➝ $13.00	Buy	00.00%	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 1/8/2025
OCS Oculis	$17.35 -0.3%	1/7/2025		Reiterated Rating	$28.00 ➝ $28.00	Buy	00.00%	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 1/7/2025
SONN Sonnet BioTherapeutics	$7.58 +7.4%	12/20/2024		Lower Price Target	$30.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Sonnet BioTherapeutics (NASDAQ:SONN) on 12/20/2024
STOK Stoke Therapeutics	$23.50 +3.3%	12/20/2024	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$24.00	Buy	00.00%	View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 12/20/2024
PRTA Prothena	$8.18 +1.5%	12/20/2024	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$40.00	Buy	00.00%	View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 12/20/2024
MNMD Mind Medicine (MindMed)	$9.48 -0.9%	12/20/2024	R. Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$20.00	Buy	00.00%	View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 12/20/2024
CGTX Cognition Therapeutics	$1.47	12/19/2024		Reiterated Rating	$11.00 ➝ $11.00	Buy	00.00%	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 12/19/2024
KRYS Krystal Biotech	$160.61 +4.3%	12/18/2024		Reiterated Rating	$212.00 ➝ $212.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 12/18/2024
TNYA Tenaya Therapeutics	$1.32 +8.2%	12/18/2024		Reiterated Rating	$18.00 ➝ $18.00	Buy	00.00%	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 12/18/2024
INOD Innodata	$69.91 +4.4%	12/13/2024		Reiterated Rating	$45.00	Buy	00.00%	View details for Chardan Capital rating of Innodata (NASDAQ:INOD) on 12/13/2024
EDIT Editas Medicine	$3.00 +10.3%	12/13/2024	Y. Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 12/13/2024
KRYS Krystal Biotech	$160.61 +4.3%	12/12/2024		Reiterated Rating	$212.00 ➝ $212.00	Buy	00.00%	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 12/12/2024
ARWR Arrowhead Pharmaceuticals	$31.51 +8.2%	12/12/2024		Reiterated Rating	$60.00 ➝ $60.00	Buy	00.00%	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/12/2024
PRQR ProQR Therapeutics	$2.19 +6.3%	12/12/2024		Reiterated Rating	$4.00 ➝ $4.00	Buy	00.00%	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 12/12/2024
CRVO CervoMed	$8.10 +4.0%	12/11/2024	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 12/11/2024
CRSP CRISPR Therapeutics	$62.94 +6.6%	12/10/2024		Reiterated Rating	$94.00 ➝ $94.00	Buy	00.00%	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 12/10/2024
FBRX Forte Biosciences	$13.21 +10.5%	12/4/2024		Reiterated Rating	$64.00 ➝ $64.00	Buy	00.00%	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 12/4/2024
SNTI Senti Biosciences	$1.39 +1.5%	12/2/2024		Reiterated Rating	$10.00 ➝ $10.00	Buy	00.00%	View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 12/2/2024
OTLK Oncobiologics	$0.99 -2.9%	12/2/2024	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of Oncobiologics (NASDAQ:OTLK) on 12/2/2024
ARWR Arrowhead Pharmaceuticals	$31.51 +8.2%	11/27/2024		Reiterated Rating	$60.00 ➝ $60.00	Buy	00.00%	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 11/27/2024
MGX Metagenomi	$2.14 +13.8%	11/20/2024		Reiterated Rating	$15.00 ➝ $15.00	Buy	00.00%	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 11/20/2024
IMRX Immuneering	$9.01 +11.6%	11/20/2024		Reiterated Rating	$13.00 ➝ $13.00	Buy	00.00%	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 11/20/2024
RGNX REGENXBIO	$9.36 +3.7%	11/20/2024		Reiterated Rating	$52.00 ➝ $52.00	Buy	00.00%	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 11/20/2024
ABUS Arbutus Biopharma	$4.42 -0.2%	11/20/2024		Reiterated Rating	$4.50 ➝ $5.00	Buy	00.00%	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/20/2024
RCKT Rocket Pharmaceuticals	$3.17 +4.6%	11/18/2024		Reiterated Rating	$62.00 ➝ $62.00	Buy	00.00%	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/18/2024
OCGN Ocugen	$1.40 +6.1%	11/18/2024		Reiterated Rating	$6.00 ➝ $6.00	Buy	00.00%	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 11/18/2024
MGTX MeiraGTx	$7.99 +9.0%	11/18/2024		Reiterated Rating	$36.00 ➝ $36.00	Buy	00.00%	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 11/18/2024
NTLA Intellia Therapeutics	$16.11 +29.8%	11/18/2024		Boost Price Target	$88.00 ➝ $91.00	Buy	00.00%	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024
FBRX Forte Biosciences	$13.21 +10.5%	11/15/2024		Boost Price Target	$3.00 ➝ $64.00	Buy	00.00%	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 11/15/2024
CGTX Cognition Therapeutics	$1.47	11/15/2024	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00 ➝ $11.00	Buy	00.00%	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/15/2024
CLSD Clearside Biomedical	$3.89 +7.8%	11/15/2024	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$90.00 ➝ $90.00	Buy	00.00%	View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 11/15/2024
CRVO CervoMed	$8.10 +4.0%	11/14/2024	D. Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$55.00 ➝ $55.00	Buy	00.00%	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 11/14/2024
TSHA Taysha Gene Therapies	$2.99 +3.1%	11/14/2024		Reiterated Rating	$7.00 ➝ $7.00	Buy	00.00%	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/14/2024
PASG Passage Bio	$7.50 +6.7%	11/14/2024		Reiterated Rating	$140.00 ➝ $140.00	Buy	00.00%	View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 11/14/2024
FDMT 4D Molecular Therapeutics	$7.13 +7.1%	11/14/2024		Reiterated Rating	$39.00 ➝ $39.00	Buy	00.00%	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 11/14/2024
ALUR Allurion Technologies	$2.07 -2.4%	11/14/2024	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	00.00%	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 11/14/2024
MCRB Seres Therapeutics	$18.03 +2.4%	11/13/2024		Reiterated Rating	$25.00 ➝ $25.00	Buy	00.00%	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 11/13/2024
RNA Avidity Biosciences	$41.81 +4.4%	11/13/2024	K. Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00 ➝ $65.00	Buy	00.00%	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 11/13/2024
DYN Dyne Therapeutics	$13.92 +5.9%	11/13/2024		Reiterated Rating	$50.00 ➝ $50.00	Buy	00.00%	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 11/13/2024
OBIO Orchestra BioMed	$2.51 +2.0%	11/13/2024		Reiterated Rating	$20.00 ➝ $20.00	Buy	00.00%	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 11/13/2024
PRME Prime Medicine	$5.12 +10.1%	11/13/2024		Lower Price Target	$17.00 ➝ $15.00	Buy	00.00%	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 11/13/2024